Thus, the UNC5A–NTN1 signaling axis is likely tilted more towards UNC5A-activated signals in ERα+/PR+ breast cancers and NTN1-generated signals in TNBC/ER− tumors. The gene discussed is NTN1; the disease is breast carcinoma.